4//SEC Filing
Hillan Kenneth J. 4
Accession 0001209191-22-058361
CIK 0001804591other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:11 PM ET
Size
5.3 KB
Accession
0001209191-22-058361
Insider Transaction Report
Form 4
Hillan Kenneth
Head of Therapeutics
Transactions
- Tax Payment
Class A Common Stock
2022-11-20$2.99/sh−4,628$13,838→ 197,162 total
Footnotes (2)
- [F1]The closing price on November 18, 2022, the fair market used for the transaction date.
- [F2]Includes 5,707 shares acquired under the 23andMe Holding Co. 2021 Employee Stock Purchase Plan on August 31, 2022.
Documents
Issuer
23andMe Holding Co.
CIK 0001804591
Entity typeother
Related Parties
1- filerCIK 0001600359
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 4:11 PM ET
- Size
- 5.3 KB